Imfinzi approved for NHS use in limited-stage small cell lung cancer

16th September 2025 Uncategorised 0

Durvalumab becomes first immunotherapy recommended for LS-SCLC patients in England and Wales

More: Imfinzi approved for NHS use in limited-stage small cell lung cancer
Source: News